Home > Insider Trading > Filing (0001567619-22-007324)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628171	Revolution Medicines Inc.	RVMD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1246842	A Mark Goldsmith	C/O Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-03-17	1,023	$18.61	185,599	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	37,032	Indirect	Trust
Common Stock	37,032	Indirect	Trust
Common Stock	266,506	Indirect	Trust

Footnotes

Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
This transaction was executed in multiple trades in prices ranging from $18.1186 to $18.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 140,000 RSUs.